JPH08505851A - 抗アンドロゲン性シクロおよびビシクロアルケン類 - Google Patents

抗アンドロゲン性シクロおよびビシクロアルケン類

Info

Publication number
JPH08505851A
JPH08505851A JP6515960A JP51596094A JPH08505851A JP H08505851 A JPH08505851 A JP H08505851A JP 6515960 A JP6515960 A JP 6515960A JP 51596094 A JP51596094 A JP 51596094A JP H08505851 A JPH08505851 A JP H08505851A
Authority
JP
Japan
Prior art keywords
compound
compound according
pharmaceutical composition
administered
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP6515960A
Other languages
English (en)
Japanese (ja)
Inventor
フォード，ラリー・シー
Original Assignee
コスモス・ファーマシューティカル・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コスモス・ファーマシューティカル・コーポレイション filed Critical コスモス・ファーマシューティカル・コーポレイション
Publication of JPH08505851A publication Critical patent/JPH08505851A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/10—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/128—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis
    • C07C29/1285—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis of esters of organic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polymerisation Methods In General (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Saccharide Compounds (AREA)
  • Liquid Crystal Substances (AREA)
JP6515960A 1993-01-15 1993-10-14 抗アンドロゲン性シクロおよびビシクロアルケン類 Ceased JPH08505851A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/004,972 1993-01-15
US08004972 US5264619B1 (en) 1993-01-15 1993-01-15 Anti-androgenic cyclo and bicyclo alkenes
PCT/US1993/009844 WO1994015900A1 (en) 1993-01-15 1993-10-14 Anti-androgenic cyclo and bicyclo alkenes

Publications (1)

Publication Number Publication Date
JPH08505851A true JPH08505851A (ja) 1996-06-25

Family

ID=21713473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6515960A Ceased JPH08505851A (ja) 1993-01-15 1993-10-14 抗アンドロゲン性シクロおよびビシクロアルケン類

Country Status (21)

Country Link
US (1) US5264619B1 (OSRAM)
EP (1) EP0679152B1 (OSRAM)
JP (1) JPH08505851A (OSRAM)
KR (1) KR960700213A (OSRAM)
CN (1) CN1051758C (OSRAM)
AT (1) ATE157342T1 (OSRAM)
AU (1) AU672265B2 (OSRAM)
BR (1) BR9307758A (OSRAM)
CA (1) CA2152588C (OSRAM)
DE (1) DE69313466T2 (OSRAM)
DK (1) DK0679152T3 (OSRAM)
ES (1) ES2107793T3 (OSRAM)
GR (1) GR3025092T3 (OSRAM)
IL (1) IL107699A0 (OSRAM)
MX (1) MX9307235A (OSRAM)
MY (1) MY109679A (OSRAM)
NO (1) NO952787L (OSRAM)
PH (1) PH30285A (OSRAM)
TW (1) TW294656B (OSRAM)
WO (1) WO1994015900A1 (OSRAM)
ZA (1) ZA938767B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4311870C2 (de) * 1993-04-10 1998-07-30 Altramed Holdings Ltd Verwendung eines Anti-Östrigens zur Therapie und Prophylaxe von Demenz-Erkrankungen
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
WO1997002041A1 (en) 1995-07-03 1997-01-23 Crandall Wilson T Transdermal and oral treatment of androgenic alopecia
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
KR20010052503A (ko) 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
WO1999062879A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
MXPA02006134A (es) 1999-12-21 2002-12-13 Guilford Pharm Inc Compuestos derivados de hidantoina, composiciones farmaceuticas y metodos de uso de los mismos.
US6768026B2 (en) * 2002-01-09 2004-07-27 John P. Mamana Compounds for blocking androgen receptors
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
US20110021869A1 (en) * 2009-07-24 2011-01-27 Hilary John Cholhan Single-incision minimally-invasive surgical repair of pelvic organ/vaginal prolapse conditions
US8410314B1 (en) 2010-06-21 2013-04-02 Bcs Business Consulting Services Pte Ltd. Method of synthesis
WO2014140655A1 (en) 2013-03-11 2014-09-18 Bcs Business Consulting Services Pte Ltd. Method of synthesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7408062A (OSRAM) * 1973-06-20 1974-12-24
US4689345A (en) * 1982-05-06 1987-08-25 Cbd Corporation Oxygenated alkyl substituted bicyclo alkanes
US4535182A (en) * 1982-08-26 1985-08-13 Sumitomo Chemical Company, Limited Process for preparing 2-cyclopentenone esters
GB8406000D0 (en) * 1984-03-07 1984-04-11 Ici Plc Olefine derivatives
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
US4963583A (en) * 1987-10-05 1990-10-16 Ciba-Geigy Corporation Beta-ionone derivatives as antifungal agents
JP2608089B2 (ja) * 1988-03-09 1997-05-07 帝人株式会社 ４−ヒドロキシ−２−シクロペンテノン類およびそれを含有する薬剤組成物
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds

Also Published As

Publication number Publication date
US5264619A (en) 1993-11-23
TW294656B (OSRAM) 1997-01-01
DE69313466D1 (en) 1997-10-02
CN1051758C (zh) 2000-04-26
DE69313466T2 (de) 1998-04-02
CA2152588C (en) 1998-05-05
CA2152588A1 (en) 1994-07-21
PH30285A (en) 1997-02-20
BR9307758A (pt) 1995-10-24
WO1994015900A1 (en) 1994-07-21
ATE157342T1 (de) 1997-09-15
EP0679152A1 (en) 1995-11-02
ES2107793T3 (es) 1997-12-01
MY109679A (en) 1997-04-30
AU672265B2 (en) 1996-09-26
DK0679152T3 (da) 1998-02-23
IL107699A0 (en) 1994-02-27
MX9307235A (es) 1994-07-29
AU5584794A (en) 1994-08-15
KR960700213A (ko) 1996-01-19
GR3025092T3 (en) 1998-01-30
EP0679152B1 (en) 1997-08-27
ZA938767B (en) 1994-06-30
NO952787D0 (no) 1995-07-13
CN1091733A (zh) 1994-09-07
US5264619B1 (en) 1996-05-14
NO952787L (no) 1995-09-01

Similar Documents

Publication Publication Date Title
JPH08505851A (ja) 抗アンドロゲン性シクロおよびビシクロアルケン類
JP2548176B2 (ja) ベンゾピラニルおよびベンゾチオピラニルベンゼン化合物、その製法並びに化粧品とひと・動物薬
JP2618225B2 (ja) 新規ベンゾノルボルネン誘導体、その製法およびそれを含む医薬または化粧組成物
TW445252B (en) Vitamin D3 analogs
HU219593B (hu) D-vitamin-származékok és eljárás ezek előállítására
JP2006507287A (ja) 核内ホルモン受容体化合物、それを用いた製品及び方法
JP3803579B2 (ja) ビタミンｄ３アナログ
JPH0255430B2 (OSRAM)
US4855322A (en) Oxygenated alkyl substituted bicyclo alkanes
JPH09511224A (ja) ビタミンｄアミンおよびアミド誘導体
JPS62221681A (ja) 新規ベンゾフラン誘導体とその製造方法ならびにこれを含有する医薬および化粧品組成物
US4689345A (en) Oxygenated alkyl substituted bicyclo alkanes
WO2013080830A1 (ja) 冷感剤及びｔｒｐｍ８活性化剤
US3683091A (en) Certain phenanthrene compounds for treatment of acne
JPH1036259A (ja) 白内障の予防または治療薬剤
US5296505A (en) Compositions of retinoids substituted with a dithiane ring, their use, and process for preparing the compounds
EP0360637B1 (fr) Nouveaux composés benzofuranniques, leur procédé de préparation, compositions pharmaceutique et cosmétique les contenant et utilisation de ces compositions
CA1262142A (en) Cycloaliphatic pharmaceutical compounds
EP0437552A1 (fr) Derives alcoyles en 17/21 de la 19-nor progesterone
CA1246604A (en) Cycloaliphatic pharmaceutical compounds
JPH06199779A (ja) トランス−▲δ２▼−１５−デオキシ−１６−ヒドロキシ−１６−メチル−ｐｇ▲ｅ１▼のメチルエステル（ｂ−４０７）
WO2006010859A1 (fr) Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
CN1558895A (zh) 含有植烷二元醇胺的治疗痤疮的组合物
WO2004013084A1 (ja) スフィンゴシノイド及びそれを含有する皮膚外用剤
JP2002145749A (ja) 化粧料

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040330

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20040809

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20040809

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040914